These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10526598

  • 1. [Chronic hepatitis-b-virus infections: new options for antiviral therapy].
    de Man RA, Honkoop P, Janssen HL, Schalm SW.
    Ned Tijdschr Geneeskd; 1999 Sep 11; 143(37):1857-61. PubMed ID: 10526598
    [Abstract] [Full Text] [Related]

  • 2. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.
    Med Sci Monit; 2002 Apr 11; 8(4):CR257-62. PubMed ID: 11951067
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct 11; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of lamivudine in HBeAg-negative chronic hepatitis B.
    Rizzetto M.
    J Med Virol; 2002 Apr 11; 66(4):435-51. PubMed ID: 11857520
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
    Bernardi M, Biselli M, Gramenzi A.
    Recenti Prog Med; 2002 Apr 11; 93(7-8):397-402. PubMed ID: 12138683
    [Abstract] [Full Text] [Related]

  • 8. Therapy of chronic hepatitis B: new goals and new treatments.
    Mauss S.
    Minerva Med; 2009 Dec 11; 100(6):447-58. PubMed ID: 20010480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY, Wang LW, Sun XM, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 11; 4(3):393-7. PubMed ID: 16109523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.
    Horiike N, Fazle Akbar SM, Michitaka K, Joukou K, Yamamoto K, Kojima N, Hiasa Y, Abe M, Onji M.
    J Clin Virol; 2005 Feb 11; 32(2):156-61. PubMed ID: 15653419
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.
    Antivir Ther; 2008 Feb 11; 13(4):571-9. PubMed ID: 18672536
    [Abstract] [Full Text] [Related]

  • 20. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouillères O, Carbonell N, Loria A, Poupon R.
    Hepatology; 2001 Sep 11; 34(3):573-7. PubMed ID: 11526544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.